Although in-treatment biopsies are not part of standard procedures in GBM clinical trials, due to the nature of GBM disease, it has been well established by our previous published reports that TSP-1 expression is increased in myeloid cells in the circulation of GBM patients treated with VT102150. This evidence concerns the gene THBS1 and glioblastoma.